ISSN: 0973-7510

E-ISSN: 2581-690X

Review Article | Open Access
Navya Sreepathi1,2, M.K. Jayanthi1, S. Jagadeep Chandra2, Shrisha Naik Bajpe3 and Ramith Ramu4
1Department of Pharmacology, JSS Medical College, JSS Academy of Higher Education and Research, Mysore – 570 015, Karnataka, India.
2Department of Microbiology, School of Life Sciences, JSS Academy of Higher Education and Research, Mysore – 570 015, Karnataka, India.
3Department of Biotechnology, Sri Dharmasthala Manjunatheshwara College (Autonomous), Ujire – 574 240, Karnataka, India.
4Department of Biotechnology and Bioinformatics, School of Life Sciences, JSS Academy of Higher Education and Research, Mysore – 570 015, Karnataka, India.
Article Number: 7663 | © The Author(s). 2022
J Pure Appl Microbiol. 2022;16(3):1519-1529. https://doi.org/10.22207/JPAM.16.3.25
Received: 07 March 2022 | Accepted: 23 June 2022 | Published online: 03 August 2022
Issue online: September 2022
Abstract

Diabetes is a noncommunicable lifestyle condition that impacts millions of individuals worldwide. Diabetes is a physiological illness that affects several different organs in the human body. Several studies have found a direct relationship between gut microbiota and diabetes control. Probiotic intervention in the treatment of diabetes mellitus has been the center of focus in the current scenario. Alteration in composition and metabolic activity of gut microbiota significantly contributes to human health. However, the key mechanism of gut microbiota in the inhibition of diabetes is not fully understood. This review discusses the effect of probiotics on diabetes and the role of gut microbiota. It emphasizes on the pharmacological effects of probiotics on diabetic symptoms like glycemic response, hypercholesterolemia, hypertension, as well as gestational diabetes.

Keywords

Diabetes, Probiotics, Effects of Probiotics, Diabetes, Glycemic Response, Hypercholesterolemia, Hypertension, Gestational Diabetes

Article Metrics

Article View: 433

Share This Article

© The Author(s) 2022. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.